Larimar Therapeutics chief medical officer Russell Clayton reports $9,999.22 share purchase
LRMR•Larimar Therapeutics Chief Medical Officer Russell Clayton bought 3,322 common shares at $3.01 each, increasing his directly owned holdings to 74,765 shares.
1. Share purchase
Clayton bought 3,322 Larimar Therapeutics common shares at $3.01 each. The purchase increased his directly owned holdings to 74,765 shares.




